INNV
BuyPremium GrowerFLAGInnovAge Holding Corp. · Healthcare · United States · $1.5B · Avg Vol: $3M/d
Premium Grower: Strong business with the market behind it, but you are paying up for it.
Insufficient evidence for a screen-pass. InnovAge Holding Corp.: fails the quant gate on value (Q55/V31/M70; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT INNOVAGE HOLDING CORP.
Read
InnovAge Holding Corp. is a leading provider of comprehensive healthcare services to frail seniors through the Program of All-Inclusive Care for the Elderly (PACE), delivering coordinated medical, social, and long-term care. Its competitive moat is its specialized integrated care model, which effectively manages complex senior health needs within a community setting, improving outcomes and reducing institutionalization. InnovAge is a prominent national player in the PACE market, addressing the unique challenges of an aging population.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 698.6M | 688.1M | 763.9M | 853.7M | 6.9% | 989.7M | 966.0M | 1.0B | 6.8% |
| EPS | -0.36 | -0.05 | -0.30 | -0.16 | -0.22 | — | -0.02 | — | — | — |
| Shares | — | 135.5M | 135.6M | 136.1M | 135.4M | -0.1% | 136.5M | — | — | — |
| Debt | — | 84.8M | 108.8M | 113.0M | 101.1M | 6.0% | 87.0M | — | — | — |
| Equity | — | 332.4M | 296.3M | 269.3M | 235.0M | -10.9% | — | — | — | — |
| Op CF | — | 27.3M | 20.2M | -36.9M | 32.9M | 6.4% | 64.7M | — | — | — |
| Inv CF | — | -40.2M | -69.5M | -26.4M | -5.5M | — | — | — | — | — |
| Fin CF | — | -6.3M | -7.9M | -7.0M | -19.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of INNV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| INNV | InnovAge Holding Corp.(you) | $1.5B | 74 | Buy |
| ASTH | Astrana Health, Inc. | $1.9B | 83 | Strong Buy |
| GMRS | GMR Solutions Inc. | $681M | 73 | Buy |
| ARDT | Ardent Health, Inc. | $1.5B | 91 | Strong Buy |
| PNTG | The Pennant Group, Inc. | $1.3B | 58 | Hold |
| HCSG | Healthcare Services Group, Inc. | $1.5B | 94 | Strong Buy |
| USPH | U.S. Physical Therapy, Inc. | $1.2B | 58 | Hold |
| GRDN | Guardian Pharmacy Services, Inc. | $2.3B | 88 | Strong Buy |
| SGRY | Surgery Partners, Inc. | $1.8B | 55 | Hold |
| AMN | AMN Healthcare Services, Inc. | $1.3B | 96 | Strong Buy |
Peer medians: ROE -31.0% · P/E 25.1x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.